Also published in World News Media Monitoring:
Athenex Announces Appointment of Jordan S. Kanfer to Board of Directors
x hide permanently

CRISPR Therapeutics Proposes Changes to the Board of Directors

World News Media Monitoring

ZUG, Switzerland and CAMBRIDGE, Mass., Feb. 26, 2020 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced it proposes to elect Doug Treco, Ph.D. to its Board of Directors...

Mentions: Nasdaq Board of Directors CRISPR Therapeutics